Update on the clinical utility and optimal use of cefditoren

about

Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication.Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults

P2860

Q36617992-67331F80-95D2-4CB3-9E66-C8677986E279 Q58617498-C14D57EC-DB2B-43F1-B71A-B51E4DC189AE

P2860

Update on the clinical utility and optimal use of cefditoren

Item

http://www.wikidata.org/entity/Q36008860

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Update on the clinical utility and optimal use of cefditoren

@ast

Update on the clinical utility and optimal use of cefditoren

@en

type

Item

label

Update on the clinical utility and optimal use of cefditoren

@ast

Update on the clinical utility and optimal use of cefditoren

@en

prefLabel

Update on the clinical utility and optimal use of cefditoren

@ast

Update on the clinical utility and optimal use of cefditoren

@en

P1476

Update on the clinical utility and optimal use of cefditoren

@en

P2093

José Barberán

http://www.w3.org/2001/XMLSchema#string

Lorenzo Aguilar

http://www.w3.org/2001/XMLSchema#string

P2860

Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid

Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model

Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.

Beta-lactam effects on mixed cultures of common respiratory isolates as an approach to treatment effects on nasopharyngeal bacterial population dynamics.

Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections.

Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).

Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009.

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.

P304

455-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJGM.S25989

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

María-José Giménez

P577

2012-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22675264

http://www.w3.org/2001/XMLSchema#string

P921

cefditoren

P932

3367410

http://www.w3.org/2001/XMLSchema#string

Update on the clinical utility and optimal use of cefditoren

about

P2860

P2860

Update on the clinical utility and optimal use of cefditoren

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932